Physician profile
Victory Akem
NPI 1033695531
$805.23
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $367 · 2023: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $253.81 | 2022-2023 | Liletta, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $121.93 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.13 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $95.58 | 2023 | Myfembree |
| Organon LLC | $91.80 | 2022-2023 | Nexplanon |
| Hologic Sales and Service, LLC | $40.82 | 2022-2023 | Aptima |
| Ethicon US, LLC | $36.37 | 2022 | |
| Myovant Sciences INC. | $20.20 | 2022 | |
| Evofem Biosciences, INC. | $15.91 | 2022 | |
| Avion Pharmaceuticals | $13.69 | 2023 | Balcoltra |
| Exeltis, USA INC. | $12.99 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victory Akem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.